The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,379.00
Bid: 4,385.00
Ask: 4,387.00
Change: -33.00 (-0.75%)
Spread: 2.00 (0.046%)
Open: 4,417.00
High: 4,451.00
Low: 4,379.00
Prev. Close: 4,412.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategy Update

25 Oct 2023 07:00

RNS Number : 1626R
Reckitt Benckiser Group PLC
25 October 2023
 

25 October 2023

 

RECKITT STRATEGY UPDATE

 

A STRONG, well-invested BUSINESS - NOW ENHANCing RETURNS TO SHAREHOLDERS

 

Reckitt today announces a strategy update and commencement of a share buyback programme following the appointment of Kris Licht as CEO on 1 October.

 

Key highlights are as follows:

· Reckitt is today a strong, well-invested business with a culture and purpose fit for the future

· We operate in attractive growth categories. Our portfolio of brands is excellent and positions us well to deliver sustainable mid-single digit like-for-like (LFL) net revenue growth over the medium term.

· We will continue to invest in product superiority and to sharpen and improve the consistency of our in-market execution, and our cost base.

· We see a clear runway for sustainable growth, with superior gross margins, and we will extend our productivity programme to focus on fixed costs to fuel both growth and earnings.

· We are well positioned to grow adjusted operating profit ahead of net revenue in the medium term.

· Our strong free cashflow generation and a healthy balance sheet enable us to announce the commencement of an enhanced shareholder returns programme:

Sustainable dividend growth (no change)

Commencing a share buyback programme. £1bn over the next 12 months, commencing imminently (new).

 

 

Outlining the strategy, Kris Licht, Chief Executive Officer, said:

 

"Reckitt today is a strong, competitive, resilient business with an inspiring purpose and a distinctive culture fit for the future. We have an excellent portfolio of market-leading, high margin brands in growth categories.

"The investments that we have made in innovation, R&D, and our supply chain have enabled us to deliver sector-leading growth over the past three and a half years. And looking forward, our pipeline of large innovation platforms gives me continuing confidence to deliver mid-single digit net revenue growth.

"We do, however, have room to sharpen and improve. We will continue to invest in the superiority of our products, work to improve the consistency of our in-market execution and optimise our cost base. At the same time, we will constantly sharpen our portfolio in line with our clear principles for portfolio value creation.

"I am pleased to have announced today our intention to commence a new £1bn share buy back programme, a clear indication of my confidence in Reckitt. 

"With our strong growth and sector leading earnings model, a clear set of priorities to sharpen and improve our business, significant free cashflow generation, and a healthy balance sheet, we are now well positioned to deliver sustainable and leading total shareholder returns."

 

 

CONFERENCE CALL DETAIlS

We will be hosting a live Q&A session for analysts and investors at 09:00 (BST) on Wednesday 25 October 2023.

 

Please click on the link below to join the live audiocast on the day:

 

https://www.reckitt.com/investors/results-and-presentations/

 

Alternatively, dial in details are as follows:

 

United Kingdom:

+44 20 4587 0498

All other locations:

+44 800 358 1035

Participant access code:

564750

 

Further Information and Contacts

Richard Joyce / Hazel Chung +44 (0)7807 418516 / +44 (0) 7408 850537

Investor Relations

Patty O'Hayer +44 (0)7825 755688

External Relations and Government Affairs

FGS

Faeth Birch +44 (0)7768 943171

 

Cautionary note concerning forward-looking statements

This announcement contains statements with respect to the financial condition, results of operations and business of Reckitt Benckiser Group plc and the Reckitt group of companies (the "Group") and certain of the plans and objectives of the Group that are forward-looking statements. Words such as ''intends', 'targets', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including targets for net revenue, operating margin and cost efficiency, are forward-looking statements. Such statements are not historical facts, nor are they guarantees of future performance.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including many factors outside the Group's control. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: the general economic, business, political, geopolitical and social conditions in the key markets in which the Group operates; the Group's ability to innovate and remain competitive; the Group's investment choices in its portfolio management; the ability of the Group to address existing and emerging environmental and social risks and opportunities; the ability of the Group to manage regulatory, tax and legal matters, including changes thereto; the reliability of the Group's technological infrastructure or that of third parties on which the Group relies including the risk of cyber-attack; interruptions in the Group's supply chain and disruptions to its production facilities; economic volatility including increases in the cost of labour, raw materials and commodities; the execution of acquisitions, divestitures and business transformation projects; product safety and quality, and the reputation of the Group's global brands; and the recruitment and retention of key management.

These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

LEI: 5493003JFSMOJG48V108

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQZLFLXBLLFBK
Date   Source Headline
1st Dec 202212:00 pmRNSTotal Voting Rights
7th Nov 20222:57 pmRNSDirectorate Change
1st Nov 20222:55 pmRNSTotal Voting Rights
26th Oct 20227:00 amRNS3rd Quarter Results
20th Oct 20224:46 pmRNSHolding(s) in Company
3rd Oct 20222:43 pmRNSTotal Voting Rights
29th Sep 20224:59 pmRNSDirector/PDMR Shareholding
16th Sep 20222:54 pmRNSDirector/PDMR Shareholding
7th Sep 202212:00 pmRNSDirector/PDMR Shareholding
1st Sep 202210:55 amRNSTotal Voting Rights
1st Sep 20227:00 amRNSDirectorate Change
11th Aug 202210:27 amRNSDirectorate Change
5th Aug 202212:07 pmRNSDirector Declaration
1st Aug 20224:07 pmRNSTotal Voting Rights
27th Jul 20227:00 amRNSHalf-year Results
19th Jul 20229:41 amRNSDirector Declaration
1st Jul 20221:34 pmRNSTotal Voting Rights
13th Jun 202211:45 amRNSDirector/PDMR Shareholding
1st Jun 202212:37 pmRNSTotal Voting Rights
23rd May 20225:28 pmRNSDirector/PDMR Shareholding
20th May 20225:30 pmRNSResult of AGM
3rd May 202212:54 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNS1st Quarter Results
27th Apr 20224:29 pmRNSNotice of AGM
14th Apr 202212:26 pmRNSAnnual Financial Report
1st Apr 20221:57 pmRNSTotal Voting Rights
22nd Mar 202212:18 pmRNSDirector/PDMR Shareholding
1st Mar 20223:39 pmRNSTotal Voting Rights
17th Feb 20227:00 amRNSReckitt FY 2021 Results
1st Feb 202210:32 amRNSTotal Voting Rights
17th Jan 20229:00 amRNSDirectorate Change
4th Jan 202211:21 amRNSTotal Voting Rights
24th Dec 20217:00 amRNSProposed Sale of E45 to Karo Pharma
1st Dec 202111:22 amRNSTotal Voting Rights
1st Nov 202111:47 amRNSTotal Voting Rights
26th Oct 202110:01 amRNSDirectorate Change
26th Oct 20217:00 amRNS3rd Quarter Results
4th Oct 20219:35 amRNSDirectorate Change
1st Oct 202111:15 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSTrading Update & Launch of Investor Seminar Series
16th Sep 20211:20 pmRNSDirector/PDMR Shareholding
9th Sep 20219:24 amRNSClosing sale of IFCN China business to Primavera
1st Sep 202111:08 amRNSTotal Voting Rights
31st Aug 20214:00 pmRNSDirector/PDMR Shareholding
4th Aug 202110:30 amRNSDirector/PDMR Shareholding
3rd Aug 20211:30 pmRNSDirector/PDMR Shareholding
2nd Aug 202112:50 pmRNSTotal Voting Rights
30th Jul 202110:57 amRNSDirector Declaration
29th Jul 20213:30 pmRNSDirector/PDMR Shareholding
28th Jul 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.